Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
AbbVie Inc.

Start price
Target price
Perf. (%)
€126.10
17.06.23
-
17.06.24
21.79%
11:14

Could be worthwhile Investment >10% per year
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€415.60
03.06.23
-
03.06.24
79.83%
11:12

buy
UCB S.A.

Start price
Target price
Perf. (%)
€81.86
31.05.23
-
31.05.24
59.81%
11:16

buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€143.60
30.05.23
-
30.05.24
1.64%
11:07

buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€307.95
30.05.23
€356.18
30.05.24
34.45%
10:56

buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€397.00
24.05.23
€464.75
24.05.24
88.26%
11:12

buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€397.00
24.05.23
€462.89
24.05.24
88.26%
11:12

buy
AstraZeneca plc

Start price
Target price
Perf. (%)
€124.30
11.11.22
€165.00
08.09.26
21.43%
10:58

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
positive Cash Flow expected
buy
Bayer AG

Start price
Target price
Perf. (%)
€50.37
10.11.22
€70.00
10.11.25
-39.05%
11:15

buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€196.52
08.01.22
€915.00
14.01.27
110.69%
10:56

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
ROE higher than 15% per year
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€70.48
30.09.16
€98.00
08.09.26
13.25%
11:08

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued